Cover Image
市場調查報告書

切除設備:技術和全球市場

Ablation Devices: Technologies and Global Markets

出版商 BCC Research 商品編碼 294446
出版日期 內容資訊 英文 183 Pages
訂單完成後即時交付
價格
Back to Top
切除設備:技術和全球市場 Ablation Devices: Technologies and Global Markets
出版日期: 2014年01月29日 內容資訊: 英文 183 Pages
簡介

切除是在治療癌症和心房纖維顫動等威脅生命的疾病時,破壞或消除功能不全的組織程序伴隨的微創外科技術。還有,這個程序,同樣也能採用於美容、整形外科、子宮肌瘤等簡易的治療。切除設備的全球市場2012年達近81億美元的規模。該市場在2013年達到88億美元的規模,之後以年複合成長率11.3%成長,預計2018年擴大到151億美元的規模。

本報告提供全球切除設備市場相關分析、市場概要及主要技術的彙整概要、各技術、產品、程序、治療法、地區的市場現況與展望分析、以及專利分析及競爭情形概括、主要加入企業簡介等彙整資料,為您概述為以下內容。

第1章 簡介

  • 調查和目的
  • 調查實施理由
  • 調查範圍
  • 主要讀者
  • 資訊來源、調查手法
  • 分析師的簡歷
  • 相關報告
  • BCC線上服務
  • 免除責任

第2章 摘要

第3章 切除市場概要

  • 切除設備:技術趨勢與創新
  • 傳統外科程序種類與缺點
  • 政府法規、醫療協會、食品醫藥品局,及國際法規機關
  • 產業結構與供應鏈流程
  • 市場影響成長人口動態、發病率及得病率,以及其他的參數
  • 癌症相關發生、得病率
  • 心臟疾病相關發生、得病率
  • 眼科相關發生、得病率
  • 主要產品相關FDA的指南
  • 補償方案
  • 市場動態
  • 需要的時間較少的切除療法
  • 全球切除設備市場的發展阻礙因素
  • 切除設備市場上的機會及課題

第4章 切除市場分析,各技術

  • 熱技術市場
  • 電力的切除療法
  • 放射線技術
  • 高頻(RFID)技術
  • RFA的利用
  • 超音波
  • 微波
  • 熱水
  • 非熱切除技術
  • 冷凍切除
  • 油壓、機器式

第5章 切除市場分析,各產品

  • 電力的
  • 電燒灼
  • 電子近距離放射療法
    • 放射線
    • 近距離放射療法
    • 高線量率(HDR)近距離放射治療
    • 脈衝線量率近距離放射治療
    • 永久性核種近距離放射治療,以及低劑量率(LDR)近距離放射治療
    • 立體定位放射治療、定位的放射線治療
    • 影像導航放射治療(IGRT)
    • 強度調控放射治療(IMRT)
    • 定位的放射線治療(SBRT)
    • 質子電子束治療
    • 高頻
    • 溫度控制射頻消融術設備
    • 液體冷卻RF切除
    • 機器人導管操縱系統
    • 光/雷射
    • 冷雷射
    • 準分子雷射
    • 超音波
    • 高能聚焦超音波療法(HIFU)
    • 磁共鳴誘導超音波(MRGUS)
    • 超音波外科系統
    • 體外震波碎石術
    • 微波切除
    • 熱水切除/子宮內膜熱水球囊切除設備
    • 冷凍切除
  • 組織接觸探針
  • 組織噴霧探針
  • 表皮、皮下冷凍切除設備
  • 機器人切除技術的發展
  • 具機器人性的性質的各種程序
  • 可動導管
  • HEARTLANDER
  • 機器人放射治療
  • 心律不整用機器人切除
  • 心導管電氣燒灼術使用的主要機器人系統

第6章 切除市場分析,各程序

  • 美容:皮膚活性化、緊膚
  • 臉皮膚活性化用高週波(RF)
  • 美容:塑身、消脂、橘皮組織的消除
  • 良性攝護腺肥大症切除
  • 經尿道針刺消融
  • 雷射、其他能源基礎的療法/鈥雷射消熔/前列腺摘出
  • 說明
  • 癌症/腫瘤切除
  • 月經過多/子宮內膜切除
  • 熱球囊程序
  • 應力性尿失禁
  • 經尿道高頻膠原蛋白變性
  • 靜脈瘤用射頻消融術(RFA)
  • 子宮肌瘤用高能聚焦超音波療法(HIFU)
  • 其他的程序

第7章 切除市場分析,各治療法

  • 癌症/腫瘤
  • 心血管
  • 眼科
  • 美容策略
    • 婦產科
    • 泌尿系統
  • 前列腺癌用冷凍切除
    • 整形外科
    • 整形手術用射頻消融術
  • 疼痛管理
    • 疼痛管理上的冷凍切除
  • 其他

第8章 競爭情形

  • 產品發表
  • 合併、收購策略
  • 夥伴關係、聯盟策略
  • 認證以及其他的策略

第9章 各地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區(ROW)

第10章 專利分析

  • 美國專利分析,各用途
  • 美國專利分析,各打入市場業者
  • 歐洲專利分析,各技術
  • 歐洲專利分析,各打入市場業者
  • 日本專利分析,各技術
  • 日本專利分析,各打入市場業者

第11章 企業簡介(產品系列、最近的趨勢、業績)

  • ACCURAY INC
  • ALCON LABORATORIES INC.
  • ANGIODYNAMICS INC.
  • ARTHROCARE CORPORATION
  • ATRICURE INC.
  • BIOSENSE WEBSTER
  • BOSTON SCIENTIFIC CORPORATION
  • BSD MEDICAL CORPORATION
  • C.R. BARD INC.
  • CONMED CORPORATION
  • COVIDIEN
  • ELEKTA AB
  • ENDOSENSE SA
  • GALIL MEDICAL LTD.
  • MEDTRONIC INC
  • MISONIX INC.
  • Olympus Corporation
  • ST. JUDE MEDICAL INC.
  • UROLOGIX INC.
  • VARIAN MEDICAL SYSTEMS INC.

第12章 附屬資料

  • 美國專利清單
  • 專利清單:歐洲
  • 專利清單:日本

圖表

目錄
Product Code: HLC163A

The global market for ablation devices reached nearly 8.1 billion in 2012. This market is expected to grow to $8.8 billion in 2013 and $15.1 billion in 2018 with a compound annual growth rate (CAGR) of 11.3% for the five-year period, 2013 to 2018.

This report provides:

  • An overview of the global market for ablation devices
  • Analyses of global market trends, with data from 2012, estiamtes for 2013, and projections of compound annual growth rates (CAGRs) through 2018
  • A breakdown of the market into segments such as types of technology, products, major market players, application, geography, and factors influencing demand
  • A look at factors inhibiting market growth such as pricing, reimbursement policies, and stringent regulatory impositions
  • Comprehensive company profiles of major players

STUDY AND OBJECTIVE

  • Define and identify key market segments and market structure in ablation technologies.
  • Measure and estimate the global ablation market and its market segments, which include technologies, product categories, therapeutic markets and geographical segmentation.
  • Identify key market dynamics and the factors impacting the global ablation market and its subsegments.
  • To identify the trends, gaps and opportunities in each of the micromarkets.
  • To focus exclusively on geographical segmentation. Analyze trends and opportunities in major regions: North America, Europe, Asia and the Rest of the World (ROW).
  • To identify major stakeholders, product portfolio and recent developments, and draw a competitive landscape for the market leaders.

STUDY BACKGROUND

Ablation is a minimally invasive surgical technique that involves destruction or removal of dysfunctional tissues to treat life-threatening diseases such as cancers, atrial fibrillation, etc. It is also equally adopted for simple treatments in cosmetology, orthopedics, uterine fibroids, etc. There is an increase in prevalence and incident rates of lifestyle-oriented diseases and an increasing need to innovate minimally and noninvasive technologies to treat them. From 15% to 20% of ischemic strokes occur due to atrial fibrillation and about 12 million people in the U.S. are expected to suffer from this condition by 2050. Deaths due to cancers are reaching alarming rates across the globe. By the end of 2013, America is expected to have about 580,350 deaths due to cancer. With numerous technologies available to control and treat cardiovascular disorders and cancer, they still remain primary causes of death. Where conventional radiation therapies have been effective and been adopted due to high awareness levels, emerging technologies such as hydro-mechanical ablation, microwave and hydrothermal are increasing hopes among patients and healthcare service providers.

An increasingly aging population on one side and increasing healthcare expenditure on the other is becoming a major burden to governments across various countries. The regulatory and financial environment is getting significantly complex even in developed economies with governments focusing on cost-containment measures. The ablation procedure in this scenario is expected to be significantly preferred due to cost effectiveness (compared to conventional surgical techniques), shorter hospital stays, shorter recovery time and lesser risk of blood loss and infections.

A high level of economic instability, growing pockets of investment in developing economies and commercialization of next-generation technologies are compelling market participants to collaborate and leverage. The current scenario requires the market players to plan exclusive strategies after an in-depth understanding of geographical, regulatory, technology and other key market factors.

SCOPE OF THE REPORT

This research report presents an in-depth analysis of the global ablation market by technologies, product categories, therapeutic segments, key procedures and geographical markets. The report includes key technologies involved in thermal ablation techniques and nonthermal ablation techniques. The report discusses the role of supply chain members from manufacturers to surgeons. The report has an in-depth analysis of key companies operating in the global ablation market. In-depth patent analysis in the report will focus on providing extensive technological trends across years and geographies such as the U.S., Europe and Japan.

The ablation devices market is mainly segmented into two classes: thermal and nonthermal technologies. Thermal technologies are further segmented into electrical, radiation, radio frequency, light, ultrasound, microwave and hydrothermal. The nonthermal technology market is segmented into cryotherapy and hydromechanical. The ablation devices technology market is further segmented on the basis of products offered for in-depth analysis of technology markets during the analysis period. The market study is detailed for technology based on procedures as well as its further implication on the therapeutic area. These two segmentations are also discussed in detailed for the given period. The market is segmented by geographical region into the Americas, Europe, Asia-Pacific and ROW. Companies profiled in this report include ConMed Corp., Varian Medical Systems Inc., Medtronic Inc., BSD Medical Corp., Olympus Corp., Urologix Inc., C.R. Bard Inc. and others.

ANALYST CREDENTIALS

Yojana Jeevane has more than four years of experience in market intelligence and business research. She has experience in the healthcare domain with respect to medical devices, and life sciences and chemical markets. She has frequently delivered research services that contain strategic recommendations and business strategies to assist the market players in forming beneficial strategies. Yojana holds a B.Sc degree in Biotechnology and a MBA degree in Marketing.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY AND OBJECTIVE
  • STUDY BACKGROUND
  • SCOPE OF THE REPORT
  • INTENDED AUDIENCE
  • SOURCE OF INFORMATION AND METHODOLOGY
  • ANALYST CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH ONLINE SERVICES
  • DISCLAIMER

CHAPTER 2 - EXECUTIVE SUMMARY

  • SUMMARY TABLE: GLOBAL MARKET FOR ABLATION DEVICES BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL MARKET FOR ABLATION DEVICES BY GEOGRAPHICAL REGION, 2012-2018 ($ MILLIONS)

CHAPTER 3 - ABLATION MARKET OVERVIEW

  • ABLATION DEVICES: TECHNOLOGY TRENDS AND INNOVATIONS
  • TYPES OF CONVENTIONAL SURGICAL PROCEDURES AND DRAWBACKS
    • HEART SURGERY
    • PLASTIC SURGERY
    • BRAIN SURGERY
    • CANCER SURGERY
    • ORTHOPEDIC SURGERY
  • GOVERNMENT REGULATIONS, MEDICAL ASSOCIATIONS, FOOD AND DRUG ADMINISTRATION, AND INTERNATIONAL REGULATORY AGENCIES
    • TABLE 1: DEVICES THAT ARE NOT YET APPROVED FOR THE TREATMENT OF ATRIAL FIBRILLATION
  • INDUSTRY STRUCTURE AND SUPPLY CHAIN PROCESS
    • ROLE OF MANUFACTURERS
    • ROLE OF DISTRIBUTORS
    • ROLE OF RESEARCH INSTITUTES AND CONSULTANTS
    • ROLE OF GOVERNMENTS
    • ROLE OF HOSPITALS AND SURGEONS
  • DEMOGRAPHICS, INCIDENCE AND PREVALENCE RATES AND OTHER PARAMETERS INFLUENCING MARKET GROWTH
  • INCIDENCES AND PREVALENCE RELATING TO CANCERS
    • TABLE 2: CANCER DEMOGRAPHICS IN THE U.S., 2013 (ESTIMATED)
    • FIGURE 1: DEATHS DUE TO PROSTATE CANCER IN THE U.K., 2011 (%)
  • INCIDENCES AND PREVALENCE RELATING TO CARDIOVASCULAR DISEASES
    • TABLE 3: CARDIOVASCULAR DEMOGRAPHICS IN THE U.S. BY AGE, 2010 (%)
    • TABLE 4: EUROPEAN UNION STATISTICS OF CARDIOVASCULAR DISEASES AND CIRCULATORY DISEASES, 2010
    • FIGURE 2: PREVALENCE OF CARDIOVASCULAR DISEASES IN ADULTS IN THE U.S. AGE GROUP 45-64 YEARS, 2000 AND 2010 (%)
  • INCIDENCES AND PREVALENCE RELATING TO OPHTHALMOLOGY
    • TABLE 5: VISUAL IMPAIRMENT STATISTICS U.S., 2000 AND 2010
    • FIGURE 3: CAUSES OF VISUAL IMPAIRMENT, 2010 (%)
    • FIGURE 4: VISUAL IMPAIRMENT PER MILLION, 2010 (THOUSANDS)
  • FDA GUIDELINES FOR SELECTED PRODUCTS
    • TABLE 6: FDA GUIDELINES FOR SELECTED PRODUCTS, 2001-2013
  • REIMBURSEMENT SCENARIO
    • CODING CHANGES FOR CARDIOLOGY
      • Ablation Codes
        • TABLE 7: ABLATION CODES
        • TABLE 8: PHYSICIAN FEE SCHEDULE CODES
      • Comparison of 2012 and 2013 Codes
        • Case Study I
          • TABLE 9: ATRIAL FIBRILLATION ABLATION, PULMONARY VEIN ISOLATION
        • Case Study II
          • TABLE 10: DIAGNOSTICS OF ELECTROPHYSIOLOGY STUDY
  • MARKET DYNAMICS
    • TECHNOLOGICAL DEVELOPMENTS
    • HIGHER RISK OF CHRONIC ILLNESSES
      • FIGURE 5: WORLD PROJECTED MORTALITY TRENDS DUE TO CARDIOVASCULAR DISEASES, 2008, 2015, 2030 (%)
      • FIGURE 6: U.S. CANCER DEMOGRAPHICS BY AGE AND GENDER, 2012
  • ABLATION THERAPY REQUIRES LESS TIME
    • LESS DAMAGE AND BLOOD LOSS
  • RESTRAINTS FOR THE GLOBAL ABLATION DEVICES MARKET
    • PRESSURE FROM REGULATORY AGENCIES
    • INSURANCE SETTLEMENT ISSUES
  • OPPORTUNITIES AND CHALLENGES FOR THE ABLATION DEVICES MARKET
    • GROWING MARKETS IN EMERGING ECONOMIES
    • NEED TO ENHANCE AWARENESS LEVELS

CHAPTER 4 - ABLATION MARKET ANALYSIS BY TECHNOLOGIES

  • TABLE 11: GLOBAL MARKET FOR ABLATION DEVICES BY TECHNOLOGY, THROUGH 2018 ($ MILLIONS)
  • THERMAL TECHNOLOGY MARKET
    • TABLE 12: GLOBAL MARKET FOR THERMAL ABLATION DEVICES BY TECHNOLOGY, THROUGH 2018 ($ MILLIONS)
  • ELECTRICAL ABLATION THERAPY
    • TABLE 13: GLOBAL MARKET FOR ELECTRICAL ABLATION THERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
  • RADIATION TECHNOLOGY
    • TABLE 14: GLOBAL MARKET FOR RADIATION ABLATION TECHNOLOGY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • Types of Radiation Ablation Techniques
      • Intensity Modulated Radiation Therapy (IMRT)
      • Image-Guided Radiation Therapy (IGRT)
      • Helical Tomography
      • Particle Therapy
      • Stereotactic Radiotherapy
      • Brachytherapy
  • RADIO FREQUENCY (RFID) TECHNOLOGY
    • TABLE 15: GLOBAL MARKET FOR RADIO FREQUENCY ABLATION TECHNOLOGY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
  • Uses of RFA
    • The Key Applications of RFA
    • Specific Application of RFID in Therapeutic Segments
      • Treatment of Liver Cancer
      • Treatment of Kidney Cancer
      • Treatment of Lung Cancer
      • Arrhythmias
      • Arthritis Pain
      • Treatment of Varicose Veins
  • LIGHT
    • TABLE 16: GLOBAL MARKET FOR LIGHT/LASER ABLATION TECHNOLOGY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
  • ULTRASOUND
    • TABLE 17: GLOBAL MARKET FOR ULTRASOUND ABLATION TECHNOLOGY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • TABLE 18: HIFU STUDIES IN KIDNEY TISSUES IN SPECIFIED COUNTRIES
    • HIFU in Prostate Cancer
    • HIFU in Primary and Secondary Liver Cancers
    • HIFU in Pancreatic Cancer
    • HIFU in Bladder Cancer
  • MICROWAVE
    • TABLE 19: GLOBAL MARKET FOR MICROWAVE ABLATION TECHNOLOGY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
  • HYDROTHERMAL
    • TABLE 20: GLOBAL MARKET FOR HYDROTHERMAL ABLATION TECHNOLOGY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
  • NONTHERMAL ABLATION TECHNOLOGY
    • TABLE 21: GLOBAL MARKET FOR NONTHERMAL ABLATION TECHNOLOGY, THROUGH 2018 ($ MILLIONS)
  • CRYOABLATION
    • TABLE 22: GLOBAL MARKET FOR CRYOABLATION TECHNOLOGY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
  • HYDROMECHANICAL
    • TABLE 23: GLOBAL MARKET FOR HYDROMECHANICAL TECHNOLOGY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)

CHAPTER 5 - ABLATION MARKET ANALYSIS BY PRODUCTS

  • ELECTRICAL
    • TABLE 24: GLOBAL MARKET FOR ELECTRICAL ABLATOR BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
  • ELECTRICAL ABLATORS
    • TABLE 25: GLOBAL MARKET FOR ELECTRICAL ABLATOR REVENUE BY PRODUCT, THROUGH 2018 ($ MILLIONS)
    • Argon Plasma/Beam Coagulator
    • Irreversible Electroporation
  • ELECTRONIC BRACHYTHERAPY
    • RADIATION
      • TABLE 26: GLOBAL MARKET FOR RADIATION PRODUCTS BY REVENUE, THROUGH 2018 ($ MILLIONS)
    • BRACHYTHERAPY
      • TABLE 27: GLOBAL MARKET FOR BRACHYTHERAPY ABLATOR BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • High-Dose-Rate (HDR) Brachytherapy
      • TABLE 28: GLOBAL MARKET FOR HIGH-DOSE-RATE BRACHYTHERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • Pulsed-Dose-Rate Brachytherapy
      • TABLE 29: GLOBAL MARKET FOR PULSE-DOSE-RATE BRACHYTHERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • Permanent Seed Brachytherapy or Low-Dose-Rate (LDR) Brachytherapy
      • TABLE 30: GLOBAL MARKET FOR PERMANENT SEED BRACHYTHERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • STEREOTACTIC RADIOSURGERY AND STEREOTACTIC RADIOTHERAPY
      • TABLE 31: GLOBAL MARKET FOR STEREOTACTIC RADIOSURGERY (SRS) AND STEREOTACTIC RADIOTHERAPY (SRT) MARKET REVENUE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • IMAGE-GUIDED RADIATION THERAPY (IGRT)
      • TABLE 32: GLOBAL MARKET FOR IMAGE-GUIDED RADIATION THERAPY (IGRT) BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • INTENSITY-MODULATED RADIATION THERAPY (IMRT)
      • TABLE 33: GLOBAL MARKET FOR INTENSITY-MODULATED RADIATION THERAPY (IMRT) BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • STEREOTACTIC BODY RADIATION THERAPY (SBRT)
      • TABLE 34: GLOBAL MARKET FOR STEREOTACTIC BODY RADIATION THERAPY (SBRT) BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • PROTON BEAM THERAPY
      • TABLE 35: GLOBAL MARKET FOR PROTON BEAM THERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • RADIO FREQUENCY
      • TABLE 36: GLOBAL MARKET FOR RADIO FREQUENCY ABLATOR MARKET BY PRODUCT, THROUGH 2018 ($ MILLIONS)
    • TEMPERATURE-CONTROLLED RADIO FREQUENCY ABLATION DEVICES
      • TABLE 37: GLOBAL MARKET FOR TEMPERATURE-CONTROLLED RADIO FREQUENCY ABLATION DEVICES BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • FLUID-COOLED RF ABLATION
      • TABLE 38: GLOBAL MARKET FOR FLUID COOLED RF ABLATION DEVICES BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • THE ROBOTIC CATHETER MANIPULATION SYSTEM
      • TABLE 39: GLOBAL MARKET FOR CATHETER MANIPULATION SYSTEM DEVICES BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • LIGHT/LASER
      • TABLE 40: GLOBAL MARKET FOR LIGHT/LASER BY PRODUCT, THROUGH 2018 ($ MILLIONS)
    • COLD LASER
      • TABLE 41: GLOBAL MARKET FOR COLD LASER DEVICES BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • EXCIMER LASER
      • TABLE 42: GLOBAL MARKET FOR EXCIMER LASER DEVICES BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • ULTRASOUND
      • TABLE 43: GLOBAL MARKET FOR ULTRASOUND ABLATION PRODUCTS, THROUGH 2018 ($ MILLIONS)
    • HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU)
      • TABLE 44: GLOBAL MARKET FOR HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) ABLATORS BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • MAGNETIC RESONANCE-GUIDED ULTRASOUND (MRGUS)
      • TABLE 45: GLOBAL MARKET FOR MAGNETIC RESONANCE-GUIDED ULTRASOUND (MRGUS) ABLATORS BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • ULTRASONIC SURGICAL SYSTEMS
      • TABLE 46: GLOBAL MARKET FOR ULTRASONIC SURGICAL SYSTEMS BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY
      • TABLE 47: GLOBAL MARKET FOR EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY PRODUCT BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • MICROWAVE ABLATION
      • TABLE 48: GLOBAL MARKET FOR MICROWAVE ABLATION PRODUCT BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • HYDROTHERMAL ABLATION/ ENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES
      • TABLE 49: GLOBAL MARKET FOR HYDROTHERMAL ABLATION PRODUCT BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • CRYOABLATION
      • TABLE 50: GLOBAL MARKET FOR CRYOABLATION PRODUCTS BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
  • TISSUE CONTACT PROBE
  • TISSUE SPRAY PROBE
  • EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES
  • ADVANCEMENT IN ROBOTIC ABLATION TECHNIQUE
  • VARIOUS PROCEDURES THAT ARE ROBOTIC IN NATURE
  • STEERABLE CATHETERS
  • HEARTLANDER
  • ROBOTIC RADIOTHERAPY
  • ROBOTIC ABLATION FOR ARRHYTHMIA
  • LEADING ROBOTIC SYSTEMS USED IN CATHETER ABLATION
    • Niobe (Stereotaxis)
    • Sensei (Hansen Medical)
    • Amigo (Catheter Robotics)
    • Artis Zeego (Siemens)
      • TABLE 51: GLOBAL MARKET FOR ROBOTIC ABLATION BY PRODUCT, THROUGH 2018 ($ MILLIONS)

CHAPTER 6 - ABLATION MARKET ANALYSIS BY PROCEDURES

  • TABLE 52: GLOBAL ABLATION MARKET BY PROCEDURE, THROUGH 2018 ($ MILLIONS)
  • AESTHETICS-SKIN REJUVENATION AND TIGHTENING
    • TABLE 53: GLOBAL MARKET FOR AESTHETICS-SKIN REJUVENATION AND TIGHTENING BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • LASER SKIN REJUVENATION
    • ILLUSTRATION: VICTORIAN COSMETIC INSTITUTE'S CASE STUDIES
  • RADIO FREQUENCY (RF) FOR FACIAL SKIN REJUVENATION
  • AESTHETICS-BODY SCULPTING, FAT REDUCTION AND REDUCTION IN THE APPEARANCE OF CELLULITE
    • TABLE 54: GLOBAL MARKET FOR AESTHETICS-BODY SCULPTING, FAT REDUCTION AND REDUCTION IN THE APPEARANCE OF CELLULITE ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • HIFU FOR FAT REDUCTION
    • ILLUSTRATION: ELSEVIER HEALTH JOURNAL
    • VACUUM MASSAGE FOR CELLULITE REDUCTION
  • BENIGN PROSTATIC HYPERPLASIA ABLATION
    • TABLE 55: GLOBAL MARKET FOR BENIGN PROSTATIC HYPERPLASIA ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • GREENLIGHT LASER PROCEDURE FOR BENIGN PROSTATE HYPERPLASIA
    • ILLUSTRATION: EUROPEAN UROLOGY CENTER
    • THERMOTHERAPY FOR BENIGN PROSTATE HYPERPLASIA
  • TRANSURETHRAL NEEDLE ABLATION
    • TABLE 56: GLOBAL MARKET FOR TRANSURETHRAL NEEDLE ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • ILLUSTRATION: DIVISION OF UROLOGY, JOHANNESBURG HOSPITAL, SOUTH AFRICA
  • LASER- AND OTHER ENERGY-BASED THERAPIES/HOLMIUM LASER ABLATION/ENUCLEATION OF THE PROSTATE
    • HOLMIUM LASER ENUCLEATION OF PROSTATE CANCER HLEOP
      • TABLE 57: GLOBAL MARKET FOR LASER- AND OTHER ENERGY-BASED ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
  • ILLUSTRATION
    • ABLATION FOR ATRIAL FIBRILLATION
      • TABLE 58: GLOBAL MARKET FOR ATRIAL FIBRILLATION ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • PAROXYSMAL ATRIAL FIBRILLATION
    • PERSISTENT ATRIAL FIBRILLATION
  • CANCER/TUMOR ABLATION
    • TABLE 59: GLOBAL MARKET FOR CANCER ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
  • MENORRHAGIA/ENDOMETRIAL ABLATION
    • TABLE 60: GLOBAL MARKET FOR MENORRHAGIA/ENDOMETRIAL ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
  • HEATED BALLOON PROCEDURE
    • SPINAL DECOMPRESSION AND DENERVATION
      • TABLE 61: GLOBAL MARKET FOR SPINAL DECOMPRESSION AND DENERVATION ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • DIAGNOSTIC MEDIAL BRANCH BLOCK (MBB)
    • RADIO FREQUENCY ABLATION (RFA) FOR BACK PAIN
  • STRESS URINARY INCONTINENCE
    • TABLE 62: GLOBAL MARKET FOR STRESS URINARY INCONTINENCE ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
  • TRANSURETHRAL RADIO FREQUENCY COLLAGEN DENATURATION
    • VARICOSE VEIN ABLATION
      • TABLE 63: GLOBAL MARKET FOR VARICOSE VEIN ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
  • RADIO FREQUENCY ABLATION (RFA) FOR VARICOSE VEINS
    • UTERINE FIBROIDS
      • TABLE 64: GLOBAL MARKET FOR UTERINE FIBROIDS ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
  • HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) FOR UTERINE FIBROIDS
  • OTHER PROCEDURES
    • ELASA EYE SURGERY

CHAPTER 7 - ABLATION MARKET ANALYSIS BY THERAPEUTICS

  • TABLE 65: GLOBAL MARKET FOR ABLATION THERAPEUTICS, THROUGH 2018 ($ MILLIONS)
  • CANCER/ONCOLOGY
    • TABLE 66: GLOBAL MARKET FOR CANCER ABLATION THERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
  • CARDIOVASCULAR
    • TABLE 67: GLOBAL MARKET FOR CARDIOVASCULAR ABLATION THERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
  • OPHTHALMOLOGY
    • TABLE 68: GLOBAL MARKET FOR OPHTHALMOLOGY ABLATION THERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
  • COSMETOLOGY
    • GYNECOLOGY
      • TABLE 69: GLOBAL MARKET FOR GYNECOLOGY ABLATION THERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • UROLOGY
      • TABLE 70: GLOBAL MARKET FOR UROLOGY ABLATION THERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
  • CRYOABLATION FOR PROSTATE CANCER
    • ORTHOPEDICS
      • TABLE 71: GLOBAL MARKET FOR ORTHOPEDICS THERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • RADIO FREQUENCY ABLATION (RFA) FOR ORTHOPEDIC TREATMENT
  • PAIN MANAGEMENT
    • CRYOABLATION IN PAIN MANAGEMENT
  • OTHERS
    • TABLE 72: GLOBAL MARKET FOR OTHER THERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS)
    • COBLATION FOR TONSILLITIS
    • PORT-WINE STAINS
    • ABLATION OF PORT-WINE STAINS

CHAPTER 8 - COMPETITIVE LANDSCAPE

  • FIGURE 7: KEY COMPETITIVE STRATEGIES*, 2010-2013 (%)
  • PRODUCT LAUNCH
    • FIGURE 8: PRODUCT LAUNCH BY COMPANY*, 2010-2013 (%)
    • TABLE 73: LIST OF KEY PRODUCT LAUNCHES ANNOUNCED, 2010-2013
  • MERGERS AND ACQUISITIONS STRATEGY
    • FIGURE 9: MERGERS AND ACQUISITIONS BY COMPANIES*, 2010-2013 (%)
    • TABLE 74: MERGERS AND ACQUISITIONS STRATEGIES BY COMPANIES, 2010-2013
  • PARTNERSHIP AND COLLABORATION STRATEGY
    • FIGURE 10: PARTNERSHIP AND COLLABORATION STRATEGIES BY COMPANIES*, 2010-2013
    • TABLE 75: PARTNERSHIP AND COLLABORATION STRATEGIES BY COMPANIES, 2010-2012
  • APPROVALS AND OTHER STRATEGIES
    • FIGURE 11: APPROVALS AND OTHER STRATEGIES BY COMPANIES*, 2010-2013 (%)
    • TABLE 76: LIST OF APPROVALS AND OTHER STRATEGIES ANNOUNCED, 2010-2013

CHAPTER 9 - GEOGRAPHICAL ANALYSIS

  • NORTH AMERICA
    • TABLE 77: ABLATION MARKET ESTIMATION FOR NORTH AMERICA, THROUGH 2018 ($ MILLIONS)
  • EUROPE
    • TABLE 78: ABLATION MARKET ESTIMATION FOR EUROPE, THROUGH 2018 ($ MILLIONS)
  • ASIA PACIFIC
    • TABLE 79: ABLATION MARKET ESTIMATION FOR ASIA PACIFIC, THROUGH 2018 ($ MILLIONS)
  • REST OF WORLD (ROW)
    • TABLE 80: ABLATION MARKET ESTIMATION FOR ROW, THROUGH 2018 ($ MILLIONS)

CHAPTER 10 - PATENT ANALYSIS

  • FIGURE 12: PATENTS REGISTERED/APPROVED IN THE U.S., EUROPE AND JAPAN, 2008-2013 (%)
  • THE U.S. PATENT ANALYSIS BY APPLICATION
    • FIGURE 13: U.S. PATENT ANALYSIS BY TECHNOLOGY, 2008-2013 (%)
  • U.S. PATENT ANALYSIS BY MARKET PARTICIPANTS
    • FIGURE 14: U.S. PATENT ANALYSIS BY MARKET PARTICIPANTS, 2008-2013 (%)
  • EUROPE PATENT ANALYSIS BY TECHNOLOGY
    • FIGURE 15: EUROPE PATENT ANALYSIS BY TECHNOLOGY, 2008-2013 (%)
  • EUROPE PATENT ANALYSIS BY MARKET PARTICIPANTS
    • FIGURE 16: EUROPE PATENT ANALYSIS BY MARKET PARTICIPANTS, 2008-2013 (%)
  • JAPAN PATENT ANALYSIS BY TECHNOLOGY
    • FIGURE 17: JAPAN PATENT ANALYSIS BY TECHNOLOGY, 2008-2013 (%)
  • JAPAN PATENT ANALYSIS BY MARKET PARTICIPANTS
    • FIGURE 18: JAPAN PATENT ANALYSIS BY MARKET PARTICIPANTS, 2008-2013 (%)

CHAPTER 11 - COMPANY PROFILES

  • ACCURAY INC
    • ACCURAY PRODUCT PORTFOLIO
      • TABLE 81: ACCURAY RECENT DEVELOPMENTS, 2010-2012
      • TABLE 82: ACCURAY FINANCIALS, 2010-2012
  • ALCON LABORATORIES INC.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 83: ALCON RECENT DEVELOPMENT, 2012
      • TABLE 84: ALCON FINANCIALS, 2010-2012
  • ANGIODYNAMICS INC.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 85: ANGIODYNAMICS RECENT DEVELOPMENTS, 2010-2012
      • TABLE 86: ANGIODYNAMICS FINANCIALS, 2010-2012
  • ARTHROCARE CORPORATION
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 87: ARTHROCARE RECENT DEVELOPMENTS, 2010
      • TABLE 88: ARTHROCARE CORPORATION FINANCIALS, 2010-2012
  • ATRICURE INC.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 89: ATRICURE RECENT DEVELOPMENTS, 2010-2011
      • TABLE 90: ATRICURE FINANCIALS, 2010-2012
  • BIOSENSE WEBSTER
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 91: BIOSENSE WEBSTER RECENT DEVELOPMENTS, 2010-2012
      • TABLE 92: BIOSENSE WEBSTER FINANCIALS, 2010-2012
  • BOSTON SCIENTIFIC CORPORATION
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 93: BOSTON SCIENTIFIC CORPORATION RECENT DEVELOPMENTS, 2010-2012
      • TABLE 94: BOSTON SCIENTIFIC CORPORATION FINANCIALS, 2010-2012
  • BSD MEDICAL CORPORATION
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 95: BSD MEDICALS RECENT DEVELOPMENTS, 2010-2012
      • TABLE 96: BSD MEDICALS FINANCIALS, 2010-2012
  • C.R. BARD INC.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 97: C.R. BARD RECENT DEVELOPMENTS, 2011-2012
      • TABLE 98: C.R. BARD FINANCIALS, 2010-2012
  • CONMED CORPORATION
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 99: CONMED RECENT DEVELOPMENTS, 2010
      • TABLE 100: CONMED FINANCIALS, 2010-2012
  • COVIDIEN
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 101: COVIDIEN RECENT DEVELOPMENTS, 2011-2013
      • TABLE 102: COVIDIEN FINANCIALS, 2010-2012
  • ELEKTA AB
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 103: ELEKTA AB RECENT DEVELOPMENTS, 2010-2013
      • TABLE 104: ELEKTA AB FINANCIALS, 2010-2012
  • ENDOSENSE SA
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 105: ENDOSENSE RECENT DEVELOPMENTS (BEFORE ACQUISITION), 2010-2011
  • GALIL MEDICAL LTD.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 106: GALIL MEDICAL LTD RECENT DEVELOPMENTS, 2011-2012
  • MEDTRONIC INC
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 107: MEDTRONIC RECENT DEVELOPMENTS, 2010-2013
      • TABLE 108: MEDTRONIC FINANCIALS, 2010-2012
  • MISONIX INC.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 109: MISONIX INC RECENT DEVELOPMENTS, 2010-2012
      • TABLE 110: MISONIX FINANCIALS, 2010-2012
  • OLYMPUS CORPORATION
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 111: OLYMPUS RECENT DEVELOPMENTS, 2010-2012
      • TABLE 112: OLYMPUS FINANCIALS, 2010-2012
  • ST. JUDE MEDICAL INC.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 113: ST. JUDE MEDICAL RECENT DEVELOPMENTS, 2010-2013
      • TABLE 114: ST. JUDE MEDICAL FINANCIALS, 2010-2012
  • UROLOGIX INC.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 115: UROLOGIX RECENT DEVELOPMENTS, 2011-2012
      • TABLE 116: UROLOGIX FINANCIALS, 2010-2012
  • VARIAN MEDICAL SYSTEMS INC.
    • ABLATION PRODUCT PORTFOLIO
      • TABLE 117: VARIAN MEDICAL SYSTEMS RECENT DEVELOPMENTS, 2010-2012
      • TABLE 118: VARIAN MEDICAL SYSTEMS INC, 2010-2012

CHAPTER 12 - APPENDIX

  • LIST OF U.S. PATENTS
    • TABLE 119: LIST OF PATENTS: UNITED STATES, 2008-2013
  • LIST OF PATENTS: EUROPE
    • TABLE 120: LIST OF PATENTS: EUROPE, 2008-2013
  • LIST OF PATENTS: JAPAN
    • TABLE 121: LIST OF PATENTS: JAPAN, 2008-2013

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL MARKET FOR ABLATION DEVICES BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 8
    • TABLE 1: DEVICES THAT ARE NOT YET APPROVED FOR THE TREATMENT OF ATRIAL FIBRILLATION 17
    • TABLE 2: CANCER DEMOGRAPHICS IN THE U.S., 2013 (ESTIMATED) 21
    • TABLE 3: CARDIOVASCULAR DEMOGRAPHICS IN THE U.S. BY AGE, 2010 (%) 23
    • TABLE 4: EUROPEAN UNION STATISTICS OF CARDIOVASCULAR DISEASES AND CIRCULATORY DISEASES, 2010 24
    • TABLE 5: VISUAL IMPAIRMENT STATISTICS U.S., 2000 AND 2010 25
    • TABLE 6: FDA GUIDELINES FOR SELECTED PRODUCTS, 2001-2013 28
    • TABLE 7: ABLATION CODES 30
    • TABLE 8: PHYSICIAN FEE SCHEDULE CODES 31
    • TABLE 9: ATRIAL FIBRILLATION ABLATION, PULMONARY VEIN ISOLATION 32
    • TABLE 10: DIAGNOSTICS OF ELECTROPHYSIOLOGY STUDY 33
    • TABLE 11: GLOBAL MARKET FOR ABLATION DEVICES BY TECHNOLOGY, THROUGH 2018 ($ MILLIONS) 41
    • TABLE 12: GLOBAL MARKET FOR THERMAL ABLATION DEVICES BY TECHNOLOGY, THROUGH 2018 ($ MILLIONS) 42
    • TABLE 13: GLOBAL MARKET FOR ELECTRICAL ABLATION THERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 42
    • TABLE 14: GLOBAL MARKET FOR RADIATION ABLATION TECHNOLOGY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 44
    • TABLE 15: GLOBAL MARKET FOR RADIO FREQUENCY ABLATION TECHNOLOGY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 47
    • TABLE 16: GLOBAL MARKET FOR LIGHT/LASER ABLATION TECHNOLOGY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 50
    • TABLE 17: GLOBAL MARKET FOR ULTRASOUND ABLATION TECHNOLOGY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 51
    • TABLE 18: HIFU STUDIES IN KIDNEY TISSUES IN SPECIFIED COUNTRIES 52
    • TABLE 19: GLOBAL MARKET FOR MICROWAVE ABLATION TECHNOLOGY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 54
    • TABLE 20: GLOBAL MARKET FOR HYDROTHERMAL ABLATION TECHNOLOGY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 54
    • TABLE 21: GLOBAL MARKET FOR NONTHERMAL ABLATION TECHNOLOGY, THROUGH 2018 ($ MILLIONS) 56
    • TABLE 22: GLOBAL MARKET FOR CRYOABLATION TECHNOLOGY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 57
    • TABLE 23: GLOBAL MARKET FOR HYDROMECHANICAL TECHNOLOGY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 58
    • TABLE 24: GLOBAL MARKET FOR ELECTRICAL ABLATOR BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 60
    • TABLE 25: GLOBAL MARKET FOR ELECTRICAL ABLATOR REVENUE BY PRODUCT, THROUGH 2018 ($ MILLIONS) 61
    • TABLE 26: GLOBAL MARKET FOR RADIATION PRODUCTS BY REVENUE, THROUGH 2018 ($ MILLIONS) 62
    • TABLE 27: GLOBAL MARKET FOR BRACHYTHERAPY ABLATOR BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 63
    • TABLE 28: GLOBAL MARKET FOR HIGH-DOSE-RATE BRACHYTHERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 63
    • TABLE 29: GLOBAL MARKET FOR PULSE-DOSE-RATE BRACHYTHERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 64
    • TABLE 30: GLOBAL MARKET FOR PERMANENT SEED BRACHYTHERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 65
    • TABLE 31: GLOBAL MARKET FOR STEREOTACTIC RADIOSURGERY (SRS) AND STEREOTACTIC RADIOTHERAPY (SRT) MARKET REVENUE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 66
    • TABLE 32: GLOBAL MARKET FOR IMAGE-GUIDED RADIATION THERAPY (IGRT) BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 67
    • TABLE 33: GLOBAL MARKET FOR INTENSITY-MODULATED RADIATION THERAPY (IMRT) BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 67
    • TABLE 34: GLOBAL MARKET FOR STEREOTACTIC BODY RADIATION THERAPY (SBRT) BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 68
    • TABLE 35: GLOBAL MARKET FOR PROTON BEAM THERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 69
    • TABLE 36: GLOBAL MARKET FOR RADIO FREQUENCY ABLATOR MARKET BY PRODUCT, THROUGH 2018 ($ MILLIONS) 69
    • TABLE 37: GLOBAL MARKET FOR TEMPERATURE-CONTROLLED RADIO FREQUENCY ABLATION DEVICES BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 70
    • TABLE 38: GLOBAL MARKET FOR FLUID COOLED RF ABLATION DEVICES BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 71
    • TABLE 39: GLOBAL MARKET FOR CATHETER MANIPULATION SYSTEM DEVICES BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 71
    • TABLE 40: GLOBAL MARKET FOR LIGHT/LASER BY PRODUCT, THROUGH 2018 ($ MILLIONS) 72
    • TABLE 41: GLOBAL MARKET FOR COLD LASER DEVICES BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 73
    • TABLE 42: GLOBAL MARKET FOR EXCIMER LASER DEVICES BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 73
    • TABLE 43: GLOBAL MARKET FOR ULTRASOUND ABLATION PRODUCTS, THROUGH 2018 ($ MILLIONS) 74
    • TABLE 44: GLOBAL MARKET FOR HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) ABLATORS BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 75
    • TABLE 45: GLOBAL MARKET FOR MAGNETIC RESONANCE-GUIDED ULTRASOUND (MRGUS) ABLATORS BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 76
    • TABLE 46: GLOBAL MARKET FOR ULTRASONIC SURGICAL SYSTEMS BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 76
    • TABLE 47: GLOBAL MARKET FOR EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY PRODUCT BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 77
    • TABLE 48: GLOBAL MARKET FOR MICROWAVE ABLATION PRODUCT BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 78
    • TABLE 49: GLOBAL MARKET FOR HYDROTHERMAL ABLATION PRODUCT BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 79
    • TABLE 50: GLOBAL MARKET FOR CRYOABLATION PRODUCTS BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 80
    • TABLE 51: GLOBAL MARKET FOR ROBOTIC ABLATION BY PRODUCT, THROUGH 2018 ($ MILLIONS) 83
    • TABLE 52: GLOBAL ABLATION MARKET BY PROCEDURE, THROUGH 2018 ($ MILLIONS) 86
    • TABLE 53: GLOBAL MARKET FOR AESTHETICS-SKIN REJUVENATION AND TIGHTENING BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 87
    • TABLE 54: GLOBAL MARKET FOR AESTHETICS-BODY SCULPTING, FAT REDUCTION AND REDUCTION IN THE APPEARANCE OF CELLULITE ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 89
    • TABLE 55: GLOBAL MARKET FOR BENIGN PROSTATIC HYPERPLASIA ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 91
    • TABLE 56: GLOBAL MARKET FOR TRANSURETHRAL NEEDLE ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 93
    • TABLE 57: GLOBAL MARKET FOR LASER- AND OTHER ENERGY-BASED ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 94
    • TABLE 58: GLOBAL MARKET FOR ATRIAL FIBRILLATION ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 95
    • TABLE 59: GLOBAL MARKET FOR CANCER ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 97
    • TABLE 60: GLOBAL MARKET FOR MENORRHAGIA/ENDOMETRIAL ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 98
    • TABLE 61: GLOBAL MARKET FOR SPINAL DECOMPRESSION AND DENERVATION ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 99
    • TABLE 62: GLOBAL MARKET FOR STRESS URINARY INCONTINENCE ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 101
    • TABLE 63: GLOBAL MARKET FOR VARICOSE VEIN ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 102
    • TABLE 64: GLOBAL MARKET FOR UTERINE FIBROIDS ABLATION PROCEDURE BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 103
    • TABLE 65: GLOBAL MARKET FOR ABLATION THERAPEUTICS, THROUGH 2018 ($ MILLIONS) 106
    • TABLE 66: GLOBAL MARKET FOR CANCER ABLATION THERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 107
    • TABLE 67: GLOBAL MARKET FOR CARDIOVASCULAR ABLATION THERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 108
    • TABLE 68: GLOBAL MARKET FOR OPHTHALMOLOGY ABLATION THERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 109
    • TABLE 69: GLOBAL MARKET FOR GYNECOLOGY ABLATION THERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 112
    • TABLE 70: GLOBAL MARKET FOR UROLOGY ABLATION THERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 113
    • TABLE 71: GLOBAL MARKET FOR ORTHOPEDICS THERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 114
    • TABLE 72: GLOBAL MARKET FOR OTHER THERAPY BY GEOGRAPHICAL REGION, THROUGH 2018 ($ MILLIONS) 116
    • TABLE 73: LIST OF KEY PRODUCT LAUNCHES ANNOUNCED, 2010-2013 122
    • TABLE 74: MERGERS AND ACQUISITIONS STRATEGIES BY COMPANIES, 2010-2013 126
    • TABLE 75: PARTNERSHIP AND COLLABORATION STRATEGIES BY COMPANIES, 2010-2012 129
    • TABLE 76: LIST OF APPROVALS AND OTHER STRATEGIES ANNOUNCED, 2010-2013 132
    • TABLE 77: ABLATION MARKET ESTIMATION FOR NORTH AMERICA, THROUGH 2018 ($ MILLIONS) 136
    • TABLE 78: ABLATION MARKET ESTIMATION FOR EUROPE, THROUGH 2018 ($ MILLIONS) 137
    • TABLE 79: ABLATION MARKET ESTIMATION FOR ASIA PACIFIC, THROUGH 2018 ($ MILLIONS) 138
    • TABLE 80: ABLATION MARKET ESTIMATION FOR ROW, THROUGH 2018 ($ MILLIONS) 140
    • TABLE 81: ACCURAY RECENT DEVELOPMENTS, 2010-2012 151
    • TABLE 82: ACCURAY FINANCIALS, 2010-2012 151
    • TABLE 83: ALCON RECENT DEVELOPMENT, 2012 152
    • TABLE 84: ALCON FINANCIALS, 2010-2012 152
    • TABLE 85: ANGIODYNAMICS RECENT DEVELOPMENTS, 2010-2012 154
    • TABLE 86: ANGIODYNAMICS FINANCIALS, 2010-2012 154
    • TABLE 87: ARTHROCARE RECENT DEVELOPMENTS, 2010 156
    • TABLE 88: ARTHROCARE CORPORATION FINANCIALS, 2010-2012 156
    • TABLE 89: ATRICURE RECENT DEVELOPMENTS, 2010-2011 157
    • TABLE 90: ATRICURE FINANCIALS, 2010-2012 158
    • TABLE 91: BIOSENSE WEBSTER RECENT DEVELOPMENTS, 2010-2012 159
    • TABLE 92: BIOSENSE WEBSTER FINANCIALS, 2010-2012 159
    • TABLE 93: BOSTON SCIENTIFIC CORPORATION RECENT DEVELOPMENTS, 2010-2012 161
    • TABLE 94: BOSTON SCIENTIFIC CORPORATION FINANCIALS, 2010-2012 161
    • TABLE 95: BSD MEDICALS RECENT DEVELOPMENTS, 2010-2012 162
    • TABLE 96: BSD MEDICALS FINANCIALS, 2010-2012 163
    • TABLE 97: C.R. BARD RECENT DEVELOPMENTS, 2011-2012 164
    • TABLE 98: C.R. BARD FINANCIALS, 2010-2012 164
    • TABLE 99: CONMED RECENT DEVELOPMENTS, 2010 165
    • TABLE 100: CONMED FINANCIALS, 2010-2012 166
    • TABLE 101: COVIDIEN RECENT DEVELOPMENTS, 2011-2013 167
    • TABLE 102: COVIDIEN FINANCIALS, 2010-2012 168
    • TABLE 103: ELEKTA AB RECENT DEVELOPMENTS, 2010-2013 169
    • TABLE 104: ELEKTA AB FINANCIALS, 2010-2012 170
    • TABLE 105: ENDOSENSE RECENT DEVELOPMENTS (BEFORE ACQUISITION), 2010-2011 171
    • TABLE 106: GALIL MEDICAL LTD RECENT DEVELOPMENTS, 2011-2012 172
    • TABLE 107: MEDTRONIC RECENT DEVELOPMENTS, 2010-2013 173
    • TABLE 108: MEDTRONIC FINANCIALS, 2010-2012 174
    • TABLE 109: MISONIX INC RECENT DEVELOPMENTS, 2010-2012 175
    • TABLE 110: MISONIX FINANCIALS, 2010-2012 176
    • TABLE 111: OLYMPUS RECENT DEVELOPMENTS, 2010-2012 177
    • TABLE 112: OLYMPUS FINANCIALS, 2010-2012 177
    • TABLE 113: ST. JUDE MEDICAL RECENT DEVELOPMENTS, 2010-2013 178
    • TABLE 114: ST. JUDE MEDICAL FINANCIALS, 2010-2012 179
    • TABLE 115: UROLOGIX RECENT DEVELOPMENTS, 2011-2012 180
    • TABLE 116: UROLOGIX FINANCIALS, 2010-2012 180
    • TABLE 117: VARIAN MEDICAL SYSTEMS RECENT DEVELOPMENTS, 2010-2012 181
    • TABLE 118: VARIAN MEDICAL SYSTEMS INC, 2010-2012 182
    • TABLE 119: LIST OF PATENTS: UNITED STATES, 2008-2013 184
    • TABLE 120: LIST OF PATENTS: EUROPE, 2008-2013 188
    • TABLE 121: LIST OF PATENTS: JAPAN, 2008-2013 194

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL MARKET FOR ABLATION DEVICES BY GEOGRAPHICAL REGION, 2012-2018 ($ MILLIONS) 8
    • FIGURE 1: DEATHS DUE TO PROSTATE CANCER IN THE U.K., 2011 (%) 22
    • FIGURE 2: PREVALENCE OF CARDIOVASCULAR DISEASES IN ADULTS IN THE U.S. AGE GROUP 45-64 YEARS, 2000 AND 2010 (%) 24
    • FIGURE 3: CAUSES OF VISUAL IMPAIRMENT, 2010 (%) 25
    • FIGURE 4: VISUAL IMPAIRMENT PER MILLION, 2010 (THOUSANDS) 26
    • FIGURE 5: WORLD PROJECTED MORTALITY TRENDS DUE TO CARDIOVASCULAR DISEASES, 2008, 2015, 2030 (%) 34
    • FIGURE 6: U.S. CANCER DEMOGRAPHICS BY AGE AND GENDER, 2012 35
    • FIGURE 7: KEY COMPETITIVE STRATEGIES*, 2010-2013 (%) 119
    • FIGURE 8: PRODUCT LAUNCH BY COMPANY*, 2010-2013 (%) 121
    • FIGURE 9: MERGERS AND ACQUISITIONS BY COMPANIES*, 2010-2013 (%) 124
    • FIGURE 10: PARTNERSHIP AND COLLABORATION STRATEGIES BY COMPANIES*, 2010-2013 127
    • FIGURE 11: APPROVALS AND OTHER STRATEGIES BY COMPANIES*, 2010-2013 (%) 131
    • FIGURE 12: PATENTS REGISTERED/APPROVED IN THE U.S., EUROPE AND JAPAN, 2008-2013 (%) 142
    • FIGURE 13: U.S. PATENT ANALYSIS BY TECHNOLOGY, 2008-2013 (%) 143
    • FIGURE 14: U.S. PATENT ANALYSIS BY MARKET PARTICIPANTS, 2008-2013 (%) 144
    • FIGURE 15: EUROPE PATENT ANALYSIS BY TECHNOLOGY, 2008-2013 (%) 145
    • FIGURE 16: EUROPE PATENT ANALYSIS BY MARKET PARTICIPANTS, 2008-2013 (%) 146
    • FIGURE 17: JAPAN PATENT ANALYSIS BY TECHNOLOGY, 2008-2013 (%) 147
    • FIGURE 18: JAPAN PATENT ANALYSIS BY MARKET PARTICIPANTS, 2008-2013 (%) 148
Back to Top